1. International Agency for Research on Cancer WHO. Breast cancer incidence and mortality worldwide in 2008; 2008. http://globocan.iarc.fr/factsheets/cancers/breast.asp.
2. Canadian Cancer Society, Public Health Agency of Canada, Statistics Canada. Canadian Cancer Statistics; 2011.
3. Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer;Ciccarese;EJC Supplements,2008
4. Eisen A, Trudeau M, Shelley W, Sinclair S, Breast Cancer Disease Site Group. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: guideline recommendations. Evidence-based series #1–18: Section 1, p. 1–9; 2008.
5. Advances in adjuvant endocrine therapy for postmenopausal women;Lin;J Clin Oncol,2008